Close
FINDING CURES TOGETHER<sup>SM</sup>
Melissa M. Vasbinder, PhD

Chairperson
Melissa M. Vasbinder, PhD
(2017-2018)
Associate Director, Medicinal Chemistry
Ribon Therapeutics, Inc.​
Wellesley, Massachusetts

Julian Blagg, DPhil

Chairperson-elect
Julian Blagg, DPhil
(2017-2018)
Deputy Director, Head of Chemistry
​Institute of Cancer Research
London, UK

Steven K. Davidsen, PhD

Past Chairperson
Steven K. Davidsen, PhD
(2017-2018)
Vice President, Oncology Discovery
AbbVie​ Inc.
North Chicago, Illinois

Stephen V. Frye, PhD

Stephen V. Frye, PhD
(2017-2019)
Professor, Chemical Biology and Medicinal Chemistry
University of North Carolina at Chapel Hill​
Chapel Hill, North Carolina

Philip Jones, PhD

Philip Jones, PhD
(2017-2019)
Executive Director and Head of Drug Discovery
UT MD Anderson Cancer Center​
Houston, Texas

Angela N. Koehler, PhD

Angela N. Koehler, PhD
(2016-2018)
Assistant Professor
Koch Institute of the Massachusetts Institute of Technology (MIT)​
Cambridge, Massachusetts

Alan G. Olivero, PhD

Alan G. Olivero, PhD
(2016-2018)
Senior Director, Discovery Chemistry
Genentech, Inc.​
South San Francisco, California

Vinod F. Patel, PhD

Vinod F. Patel, PhD
(2015-2019)
Chief Scientific Officer
APC Therapeutics
Acton, Massachusetts

Ian P. Street, PhD

Ian P. Street, PhD
(2017-2019)
Chief Scientfic Officer, Cancer Therapeutics CRC
Walter & Eliza Hall Institute of Medical Research​
Parkville, Parkville, VIC, Australia

Zhao-Kui (ZK) Wang, PhD

Zhao-Kui (ZK) Wang, PhD
(2017-2018)
Head of Chemistry
Janssen Pharmaceutical Companies of Johnson & Johnson​
Shanghai, China

John (Yuan) Wang, PhD

John (Yuan) Wang, PhD
(2016-2018)
Distinguished Scientist, Head of Target Modulation
Eisai, Inc.
Andover, Massachusetts